Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Stem Cells Translational Medicine
|
August 16, 2021
IFN-γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease
Fiona Carty, Hazel Dunbar, Ian J Hawthorne, et al.
Cytotherapy
|
June 13, 2012
Development of a surrogate angiogenic potency assay for clinical-grade stem cell production
Nicholas Lehman, Rochelle Cutrone, Amy Raber, et al.
Cytotherapy
|
November 2, 2013
Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII
Gregory G Burrows, Richard T Maziarz, Karen Hunady, et al.
Transplantation and Cellular Therapy
|
March 21, 2022
UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities
Maude Dumont-Lagacé, Albert Feghaly, Marie-Christine Meunier, et al.
The Journal of Cell Biology
|
October 1, 2003
Compartmentalization of integrin alpha6beta4 signaling in lipid rafts
Laurent Gagnoux-Palacios, Michael Dans, Wouter van't Hof, et al.
Transplantation and Cellular Therapy
|
September 19, 2023
Corrigendum to' UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities' [Transplantation and Cellular Therapy 28/7 (2022) 410-410
Maude Dumont-Lagacé, Albert Feghaly, Marie-Christine Meunier, et al.
Cellular Immunology
|
November 22, 2008
Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease
Magdalena Kovacsovics-Bankowski, Philip R Streeter, Kelsey A Mauch, et al.
Scientific Reports
|
May 22, 2021
Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability
Jeong-Su Do, Daniel Zwick, Jonathan D Kenyon, et al.
Stem Cells Translational Medicine
|
October 9, 2013
Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing
Shannon Eaker, Myriam Armant, Harvey Brandwein, et al.
Cytotherapy
|
December 25, 2012
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry
Christopher A Bravery, Jessica Carmen, Timothy Fong, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Stem Cells Translational Medicine
|
August 16, 2021
IFN-γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease
Fiona Carty, Hazel Dunbar, Ian J Hawthorne, et al.
Cytotherapy
|
June 13, 2012
Development of a surrogate angiogenic potency assay for clinical-grade stem cell production
Nicholas Lehman, Rochelle Cutrone, Amy Raber, et al.
Cytotherapy
|
November 2, 2013
Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII
Gregory G Burrows, Richard T Maziarz, Karen Hunady, et al.
Transplantation and Cellular Therapy
|
March 21, 2022
UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities
Maude Dumont-Lagacé, Albert Feghaly, Marie-Christine Meunier, et al.
The Journal of Cell Biology
|
October 1, 2003
Compartmentalization of integrin alpha6beta4 signaling in lipid rafts
Laurent Gagnoux-Palacios, Michael Dans, Wouter van't Hof, et al.
Transplantation and Cellular Therapy
|
September 19, 2023
Corrigendum to' UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities' [Transplantation and Cellular Therapy 28/7 (2022) 410-410
Maude Dumont-Lagacé, Albert Feghaly, Marie-Christine Meunier, et al.
Cellular Immunology
|
November 22, 2008
Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease
Magdalena Kovacsovics-Bankowski, Philip R Streeter, Kelsey A Mauch, et al.
Scientific Reports
|
May 22, 2021
Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability
Jeong-Su Do, Daniel Zwick, Jonathan D Kenyon, et al.
Stem Cells Translational Medicine
|
October 9, 2013
Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing
Shannon Eaker, Myriam Armant, Harvey Brandwein, et al.
Cytotherapy
|
December 25, 2012
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry
Christopher A Bravery, Jessica Carmen, Timothy Fong, et al.
Page
of 3